Antitumor Activities and Pharmacodynamic Biomarkers of a Novel and Orally Available Small Molecule IAP Antagonist

被引：0
|
作者：
Sumi, H.
Yabuki, M.
Iwai, K.
Hashimoto, K.
Kosugi, Y.
Yoshimatsu, M.
Ishikawa, T.
Yoshida, S.
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71871-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [21] Discovery of an Orally Available PAR-1 Antagonist as a Novel Antiplatelet Agent
    Lee, Sunkyung
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (04) : 515 - 517
  • [22] Discovery of an orally available PAR-1 antagonist as a novel antiplatelet agent
    Sunkyung Lee
    Archives of Pharmacal Research, 2011, 34 : 515 - 517
  • [23] Pharmacodynamic Biomarkers in the Phase 1 Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
    Andreeff, Michael
    Kojima, Kensuke
    Ruvolo, Vivian
    Younes, Anas
    Wei, Wei
    Konopleva, Marina
    Duvvuri, Seshagiri
    Huang, Xuelin
    Wu, Lin
    Jukofsky, Lori
    Vassilev, Lyubomir
    Zhi, Jianguo
    Geho, David
    Nichols, Gwen
    BLOOD, 2011, 118 (21) : 671 - 671
  • [24] In vitro and in vivo antitumor activities of a small and novel synthetic molecule: A potential therapy for hepatocellular carcinoma
    Batarseh, K. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] Pharmacologic characterization of the novel, orally available endothelin-A-selective antagonist SB 247083
    Douglas, SA
    Nambi, P
    Gellai, M
    Luengo, JI
    Xiang, TN
    Brooks, DP
    Ruffolo, RR
    Elliott, TD
    Ohlstein, EH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S273 - S276
  • [26] Discovery and pre-clinical development of an orally available small molecule antagonist targeting the CD47/SIRPa pathway for cancer immunotherapy
    Sasikumar, Pottayil
    Gundala, Chennakrishna
    Balasubramanian, Wesley
    Naremaddepalli, Sudarshan
    Bhumireddy, Archana
    Patil, Sandeep
    Dhudashiya, Amit
    Rayavarapu, Vijaysai
    Lakshminarasimhan, Anirudha
    Dodheri, Samiulla
    Aithal, Kiran
    Daginakatte, Girish
    Ramachandra, Murali
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [27] An orally available small molecule inhibitor for synthetic lethal targeting of MYC expressing tumors
    Shi, Qiong
    Zhang, Ting
    Kalashova, Julia
    Li, Jinhua
    Yang, Chenglu
    Li, Hongmei
    Zhou, Xiaohu
    Long, Yan
    Abuliezi, Yidan Xia
    Lv, Gang
    Yu, Duo
    Zhang, Shenqiu
    Zhang, Jing
    Allen, Thaddeus D.
    Liu, Hong
    Yang, Dun
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [28] Discovery of Nonpeptide, Orally Available Small Molecule GLP-1 Receptor Agonists
    Im, A-Rang
    Park, Jung-Eun
    Hong, Dahae
    Je, In-Gyu
    Kim, Jung Ho
    Chang, Min Whan
    Hong, Chang-Hee
    Shin, Jae Eui
    Sohn, Te-Ik
    Jun, Yearin
    Jang, Eunhye
    Yoo, Yeongran
    Jeon, Woojin
    An, Kyungmi
    DIABETES, 2021, 70
  • [29] A small molecule pan Id protein antagonist shows strong antitumor activity
    Wojnarowicz, Paulina M.
    Desai, Bina
    Chin, Yvette
    Lee, Sang Bae
    Garcia-Cao, Marta
    Ouerfelli, Ouathek
    Yang, Guangli
    Xu, Sijia
    Goldgur, Yehuda
    Miller, Meredith A.
    Chaudhary, Jaideep
    Garland, William A.
    Albanese, Steven K.
    Soni, Rajesh
    Philip, John
    Norton, Larry
    Rosen, Neal
    Hendrickson, Ronald C.
    Zhou, Xi Kathy
    Iavarone, Antonio
    Dannenberg, Andrew J.
    Chodera, John D.
    Pavletich, Nikola
    Lasorella, Anna
    Benezra, Robert
    CANCER RESEARCH, 2017, 77
  • [30] The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo
    Jiang, Yongsheng
    Meng, Qinghua
    Chen, Bo
    Shen, Haiyu
    Yan, Bing
    Sun, Baoyou
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (01) : 293 - 299
12345